does blue cross blue shield cover glp 1 meds GLP-1 Can employers and payers afford
Description
David Lassen, vice president of pharmacy clinical services, and Marci Chodroff, vice president and medical director at Prime Therapeutics, share more about the latest GLP-1 insights from ongoing research
My take: GLP-1RAs may become more than metabolic drugs, but oncology needs prospective cancer-outcome data before calling this prevention
GLP-1 Medications in 2026: Medical Supervision & Micro-Dosing Matter | Dr
Truven identified three major issues that payers are encountering with total population management as it relates to GLP-1 coverage.
Most semaglutide users experience nausea and digestive changes that peak within the first 2-4 weeks, then gradually improve over 8-12 weeks as the body adapts to the medication
